This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: CLVS ENDP THC WRB

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Clovis Oncology (CLVS) was upgraded at Piper Jaffray to overweight from neutral. $100 price target. Company offered positive CO-1686 data at ASCO, Piper Jaffray said.

Con-way (CNW) was upgraded at Bank of America to buy from underperform. $46 price target. The Freight segment is improving faster than expected, BofA said.

Citrix Systems (CTXS) was downgraded at Berenberg to sell. $49 price target. Legacy business could lag, Berenberg said.

Endo Health (ENDP) was downgraded at Cantor Fitzgerald to sell from hold. $30 price target. Expect a prolonged restructuring period, Cantor said.

Endo Health was upgraded at Leerink Swann. $48 price target. Expectations have come down, and 2013 guidance is now achievable, Leerink Swann said.

First Horizon National (FHN) was downgraded at Morgan Stanley to equal weight. There is limited near-term upside as the stock has outperformed its peers since the first quarter of 2012, Morgan Stanley said. http://www.thestreet.com/story/11942921/1/sodastream-could-be-a-threat-to-big-soda.html?kval=dontmiss


Haemonetics (HAE) was initiated with a market outperform rating at JMP Securities. The company's leading market position will be bolstered by M&A, and significant margin expansion is expected ahead, JMP said. Price target is $52.

Lifepoint (LPNT) was upgraded at Credit Suisse to outperform from neutral. Nonurban hospitals are best positioned for health care reform, Credit Suisse said.

LRR Energy (LRE) was downgraded to sell at TheStreet Ratings.

Oracle (ORCL) was downgraded at Berenberg to sell. $28 price target. Company may lag the pace of innovation in the software sector, Berenberg said.


Realpage (RP) was downgraded to sell at TheStreet Ratings.

Tenet Healthcare (THC) was upgraded at Deutsche Bank to buy. $55 price target. Stock is attractive, following the recent pullback, Deutsche Bank said.

VMWare (VMW) was downgraded at Berenberg to sell. $57 price target. Company may be left behind by new technology trends, Berenberg said.

WR Berkley (WRB) was upgraded at Bank of America/Merrill Lynch to buy from neutral. $46 price target. Stock is attractive, following a 12% pullback, BofA/Merrill said.

Stock Comments / EPS Changes

Brown-Forman (BF.B) estimates were reduced at UBS. Lower volume and pricing increased, said UBS.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs